Other Comprehensive Income (Loss)
Revolution Medicines, Inc. Other Comprehensive Income (Loss) decreased by 25.5% to -$457.67M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 114.8%, from -$213.03M to -$457.67M. Over 4 years (FY 2021 to FY 2025), Other Comprehensive Income (Loss) shows a downward trend with a 56.6% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
A large positive value suggests favorable currency or market movements, while a large negative value indicates potential future volatility in equity.
Detailed definition
This represents the aggregate of all items of other comprehensive income or loss, which are excluded from net income und...
Peer comparison
Standardized across all public companies under GAAP/IFRS reporting requirements.
tmusz_other_comprehensive_income_lossHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$46.90M | -$46.90M | -$46.90M | -$62.53M | -$62.53M | -$62.53M | -$62.53M | -$66.87M | -$98.99M | -$108.05M | -$160.12M | -$117.75M | -$133.90M | -$150.61M | -$197.06M | -$213.03M | -$248.19M | -$303.39M | -$364.77M | -$457.67M |
| QoQ Change | — | +0.0% | +0.0% | -33.3% | +0.0% | +0.0% | +0.0% | -7.0% | -48.0% | -9.2% | -48.2% | +26.5% | -13.7% | -12.5% | -30.8% | -8.1% | -16.5% | -22.2% | -20.2% | -25.5% |
| YoY Change | — | — | — | — | -33.3% | -33.3% | -33.3% | -7.0% | -58.3% | -72.8% | -156.1% | -76.1% | -35.3% | -39.4% | -23.1% | -80.9% | -85.4% | -101.4% | -85.1% | -114.8% |
Other Comprehensive Income (Loss) at Other Companies
Frequently Asked Questions
- What is Revolution Medicines, Inc.'s other comprehensive income (loss)?
- Revolution Medicines, Inc. (RVMD) reported other comprehensive income (loss) of -$457.67M in Q1 2026.
- How has Revolution Medicines, Inc.'s other comprehensive income (loss) changed year-over-year?
- Revolution Medicines, Inc.'s other comprehensive income (loss) decreased by 114.8% year-over-year, from -$213.03M to -$457.67M.
- What is the long-term trend for Revolution Medicines, Inc.'s other comprehensive income (loss)?
- Over 4 years (2021 to 2025), Revolution Medicines, Inc.'s other comprehensive income (loss) has grown at a 56.6% compound annual growth rate (CAGR), from -$187.58M to -$1.13B.
- What does other comprehensive income (loss) mean?
- The total of all gains and losses that are recorded directly in equity rather than through the income statement.